Explaining alcohol and medication risks for people aging with HIV
Risk Communication Core
This project creates clear, personalized ways to explain the risks of drinking alcohol and taking many medicines for people aging with HIV.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11172520 on NIH RePORTER |
What this research studies
This effort uses the Information-Motivation-Behavioral Skills (IMB) approach to build messages and tools that help you understand how alcohol and multiple medicines can interact and cause harm. A Risk Communication Resource Core made up of experts in behavioral health, mixed methods, shared decision making, pharmaco-genomics, and clinical care will guide the work. The team will gather patient input through interviews and surveys and use that feedback to make communication tools that are easy to understand and use in clinic visits. These tools are meant to support conversations with your providers and help you make safer choices about alcohol and medications.
Who could benefit from this research
Good fit: Ideal candidates are people aging with HIV who drink alcohol and take multiple prescription medicines, especially those worried about side effects or interactions.
Not a fit: People without HIV, those who do not drink alcohol, or those taking only a single medication are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, people aging with HIV could get clearer, personalized advice that reduces harmful drinking and unsafe medication combinations, improving safety and health outcomes.
How similar studies have performed: The IMB model has been used successfully for decades to change health behaviors, but applying it specifically to alcohol use plus polypharmacy in older adults with HIV is a newer application.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Hsieh, Evelyn — Yale University
- Study coordinator: Hsieh, Evelyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.